average monthly weight loss on glp 1 GLP-1 Agonists Drugs Market Report, 2025-2030 Average Monthly Weight Loss on

The global thrombopoietin receptor agonists market was estimated at US$ 1.85 billion in 2023 and is projected to grow to US$ 3.74 billion by 2034, rising at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2034

While metabolic/bariatric surgeons had long recognized these beneficial attributes following metabolic/bariatric surgery, the discovery that these agents could result in similar health benefits was a revelation to many clinicians

Satomi A, Murakami S, Hashimoto T, Ishida K, Matsuki M, Sonoda M

These compounds may remain detectable for 23 weeks or longer, depending on injection dose, frequency, and test method